Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04496284 · ClinicalTrials.gov registry record · NA
Embryo Transfer Outcomes After Vitrification With Slush Nitrogen Compared to Liquid Nitrogen
A NA study, sponsored by Reproductive Medicine Associates of New Jersey.
- Completed
- Registry status
- NA
- Development phase
- 253
- Enrollment target
NCT04496284: Completed NA study, sponsored by Reproductive Medicine Associates of New Jersey.
NCT04496284 is a NA study that has completed, run by Reproductive Medicine Associates of New Jersey. The registered enrollment target is 253 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (82% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04496284, a NA study, has completed, sponsored by Reproductive Medicine Associates of New Jersey.
- COMPLETED
- Registry status
- NA
- Development phase
- 253 participants
- Enrollment target
Study Summary
The proposed study is a single-blind randomized controlled trial which seeks to characterize implantation rates following embryo vitrification and subsequent warming with both slush nitrogen and liquid nitrogen. After warming, implantation rates and pregnancy outcomes will be assessed.
Primary Outcome
fetal heart beat present upon discharge at 8 weeks
Interventions
- OTHER Vitrification via slush nitrogen
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 253 participants |
| Start Date | 2020-09-05 |
| Est. Completion | 2022-12-20 |
| Phase | NA |
What the finished NCT04496284 record still lists
NCT04496284 is an interventional study that assigns participants to a tested intervention. The registered 253 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (82% lower).
The record links to 0 conditions, and to 1 intervention - of which Vitrification via slush nitrogen is the first listed.
NCT04496284 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04496284 about?
NCT04496284 is a clinical study titled "Embryo Transfer Outcomes After Vitrification With Slush Nitrogen Compared to Liquid Nitrogen". The proposed study is a single-blind randomized controlled trial which seeks to characterize implantation rates following embryo vitrification and subsequent warming with both slush nitrogen and liquid nitrogen. After warming, implantation rates and pregnancy outcomes will be assessed.
What is the current status of trial NCT04496284?
This trial is currently completed. It is a NA study. The enrollment target is 253 participants. The study started on 2020-09-05. Estimated completion is 2022-12-20.
What interventions are being tested in trial NCT04496284?
The interventions under investigation include: Vitrification via slush nitrogen (OTHER).
Who is sponsoring clinical trial NCT04496284?
This trial is sponsored by Reproductive Medicine Associates of New Jersey, which has 51 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04496284's enrollment target sits among peer trials
253 407th of 2000 higher than 1,594 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04390737 · 254 participants · Phase 1
Evaluate the Safety and Clinical Activity of HH2853
- NCT04677647 · 254 participants · NA
OurChild: A Health IT Solution to Reduce Minority Health Disparities
- NCT05503797 · 254 participants · Phase 2
A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
- NCT06167317 · 254 participants · Phase 1
Study of GS-0201 Alone and in Combination in Participants With Advanced Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI